Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01869777 · OUTCOME

Overall Survival

Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · Source last updated 2020-08-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Days
Interval / dispersion
95% Confidence Interval
Time frame
Up to 2 years

What was measured

Association between overall survival and standardized phase angle will be evaluated using a Cox proportional hazards model.

Groups in this outcome

Diagnostic (Bioelectric Impedance Analysis)

Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diagnostic (Bioelectric Impedance Analysis)101

Reported measurements

Source class 1
Values in Days · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Diagnostic (Bioelectric Impedance Analysis)532Not reported336808Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        336
        upper Limit
        808
        value
        532
denoms
  1. counts
    1. group Id
      OG000
      value
      101
    units
    Participants
description
Association between overall survival and standardized phase angle will be evaluated using a Cox proportional hazards model.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis
    id
    OG000
    title
    Diagnostic (Bioelectric Impedance Analysis)
param Type
MEDIAN
reporting Status
POSTED
time Frame
Up to 2 years
title
Overall Survival
type
SECONDARY
unit Of Measure
Days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice